You are using an older browser version. Please use a supported version for the best MSN experience.

CAMBREX CORPORATION

NYSE: CBM
59.62
+0.09
+0.14%

Sector

Healthcare

Industry

Pharmaceuticals

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the subsidiaries, including Cambrex Charles City, Inc., Cambrex Karlskoga AB and Cambrex Profarmaco Milano S.r.l. Its products consist of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It delivers services, such as custom organic synthesis and process development; current good manufacturing practices (cGMP) manufacturing of API and intermediates from grams to hundreds of kilograms; cGMP analytical services; controlled substance research and development (R&D) and manufacture, Schedule II-V, and contract research. It has API R&D and cGMP facilities in the United States and Europe. It supplies over 90 generic APIs.

Key People

Steven Klosk

President, Chief Executive Officer, Director

Shawn Cavanagh

Chief Operating Officer, Executive Vice President

Gregory Sargen

Chief Financial Officer, Executive Vice President, Corporate Development and Strategy

Samantha Hanley

Vice President, General Counsel,Corporate Secretary

James Farrell

Vice President and Corporate Controller

  • Cambrex Corp

  • 1 Meadowlands Plz

  • E RUTHERFORD, NJ 07073-2150

  • US.Map

  • Phone: +1 201 8043000

  • Fax: +1 201 8049852

  • https://www.cambrex.com

Incorporated

1983

Employees

1,732

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 4/24/2019

    • GLASSELL CLAES

    • Grant

    • 2,247

    • NA

    • NA

    • 4/24/2019

    • HARRIGAN KATHRYN RUDIE

    • Grant

    • 2,247

    • NA

    • NA

    • 4/24/2019

    • KAUFTHAL ILAN

    • Grant

    • 2,247

    • NA

    • NA

    • 4/24/2019

    • HAMPL BERNHARD

    • Grant

    • 2,247

    • NA

    • NA

    • 4/24/2019

    • BROWN GREGORY B

    • Grant

    • 2,247

    • NA

    • NA

    • 4/24/2019

    • YANAI SHLOMO

    • Grant

    • 2,247

    • NA

    • NA

    • 4/24/2019

    • GRABOWSKY (LOUIS J)

    • Grant

    • 2,247

    • NA

    • NA

    • 2/15/2019

    • KLOSK STEVEN MARK

    • Grant

    • 20,000

    • NA

    • NA

    • 2/15/2019

    • SARGEN GREGORY P

    • Grant

    • 12,000

    • NA

    • NA

    • 2/15/2019

    • SARGEN GREGORY P

    • Sold

    • 5,802

    • 37.45

    • 217,284.90

    • 2/15/2019

    • CAVANAGH SHAWN P

    • Grant

    • 14,000

    • NA

    • NA

    • 2/15/2019

    • CAVANAGH SHAWN P

    • Sold

    • 6,769

    • 37.60

    • 254,514.40

    • 1/31/2019

    • HANLEY (SAMANTHA)

    • Grant

    • 1,131

    • NA

    • NA

    • 1/31/2019

    • CAVANAGH SHAWN P

    • Grant

    • 7,264

    • NA

    • NA

    • 1/31/2019

    • SARGEN GREGORY P

    • Grant

    • 6,227

    • NA

    • NA

    • 1/31/2019

    • KLOSK STEVEN MARK

    • Grant

    • 10,378

    • NA

    • NA

    • 12/28/2018

    • KAUFTHAL ILAN

    • Sold

    • 13,066

    • NA

    • NA

    • 10/23/2018

    • KLOSK STEVEN MARK

    • Sold

    • 20,000

    • 55.27

    • 1,105,436.00

    • 10/23/2018

    • KLOSK STEVEN MARK

    • NA

    • 20,000

    • 17.81

    • 356,200.00

    • 9/4/2018

    • KLOSK STEVEN MARK

    • Sold

    • 55,000

    • 66.83

    • 3,675,650.00

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 4/24/2019

      • GLASSELL CLAES

      • Grant

      • 2,247

      • NA

      • NA

      • 4/24/2019

      • HARRIGAN KATHRYN RUDIE

      • Grant

      • 2,247

      • NA

      • NA

      • 4/24/2019

      • KAUFTHAL ILAN

      • Grant

      • 2,247

      • NA

      • NA

      • 4/24/2019

      • HAMPL BERNHARD

      • Grant

      • 2,247

      • NA

      • NA

      • 4/24/2019

      • BROWN GREGORY B

      • Grant

      • 2,247

      • NA

      • NA

      • 4/24/2019

      • YANAI SHLOMO

      • Grant

      • 2,247

      • NA

      • NA

      • 4/24/2019

      • GRABOWSKY (LOUIS J)

      • Grant

      • 2,247

      • NA

      • NA

      • 2/15/2019

      • KLOSK STEVEN MARK

      • Grant

      • 20,000

      • NA

      • NA

      • 2/15/2019

      • SARGEN GREGORY P

      • Grant

      • 12,000

      • NA

      • NA

      • 2/15/2019

      • SARGEN GREGORY P

      • Sold

      • 5,802

      • 37.45

      • 217,284.90

      • 2/15/2019

      • CAVANAGH SHAWN P

      • Grant

      • 14,000

      • NA

      • NA

      • 2/15/2019

      • CAVANAGH SHAWN P

      • Sold

      • 6,769

      • 37.60

      • 254,514.40

      • 1/31/2019

      • HANLEY (SAMANTHA)

      • Grant

      • 1,131

      • NA

      • NA

      • 1/31/2019

      • CAVANAGH SHAWN P

      • Grant

      • 7,264

      • NA

      • NA

      • 1/31/2019

      • SARGEN GREGORY P

      • Grant

      • 6,227

      • NA

      • NA

      • 1/31/2019

      • KLOSK STEVEN MARK

      • Grant

      • 10,378

      • NA

      • NA

      • 12/28/2018

      • KAUFTHAL ILAN

      • Sold

      • 13,066

      • NA

      • NA

      • 10/23/2018

      • KLOSK STEVEN MARK

      • Sold

      • 20,000

      • 55.27

      • 1,105,436.00

      • 10/23/2018

      • KLOSK STEVEN MARK

      • NA

      • 20,000

      • 17.81

      • 356,200.00

      • 9/4/2018

      • KLOSK STEVEN MARK

      • Sold

      • 55,000

      • 66.83

      • 3,675,650.00

      • 9/4/2018

      • KLOSK STEVEN MARK

      • NA

      • 55,000

      • 17.81

      • 979,550.00

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon